Highest-materiality recent filing
Clarivate sells Life Sciences & Healthcare business to Altaris for $600M
Purchase price $600M: $500M cash at close, $25M deferred, $75M senior note.
Clarivate sells Life Sciences & Healthcare segment to Altaris for $600M
Deal value $600M: $500M cash at close, $25M deferred cash, $75M seller note.
Clarivate appoints Simon Webster as President of IP segment; Maroun Mourad departs
Maroun Mourad, President IP, will depart June 9, 2026, and remain in advisory role through Sept 30, 2026.
Clarivate shareholders elect directors, approve compensation, ratify auditors at 2026 AGM
All 10 director nominees elected; votes in favor ranged from 92.0% to 99.9% of votes cast.
Clarivate reports Q1 2026 earnings: organic revenue up 0.6%, reaffirms full-year outlook
Total revenues $585.5M, down 1.4% from prior year; organic revenue up 0.6%.
Clarivate amends executive severance plan; CEO now eligible, good reason triggers added
CEO added as eligible ESP participant under amended severance plan.
Clarivate Q4 revenue $617M, down 7%; pursues LS&H sale; FY26 FCF ~$400M
Q4 net income $3.1M vs loss $191.8M; adjusted EPS $0.20 vs $0.21. Full-year adjusted EBITDA $1,001.8M.
Clarivate posts AI-themed webinar; no financial updates or material news
Feb 3, 2026: Posted 'Intelligence Amplified in the Age of AI' webinar to ir.clarivate.com.
Clarivate redeems remaining $100M 2026 notes; buys back $225M shares in FY2025
Redeemed remaining $100M principal of 4.50% senior secured notes due 2026 on Jan 30, 2026, using cash on hand.
Clarivate Q3 revenue flat at $623.1M, net loss narrows; raises 2025 revenue outlook
Organic ACV grew 1.6% YoY; recurring revenue mix improved to 88% of total revenue (up 800 bps).
Clarivate increases revolving credit facility by $75M to $775M total
Amendment No. 8 raised revolver commitments from $700M to $775M.
Clarivate appoints Maroun S. Mourad as President, IP; Gordon Samson to retire by year-end
Gordon Samson to depart President, IP role on Sept 7, 2025; will remain non-executive until Dec 31, 2025.
Clarivate Q2 revenue $621.4M (-4.4% YoY); organic growth 0.5%; reaffirms 2025 outlook
Total revenue $621.4M, down 4.4% YoY due to divestitures; organic revenue +0.5%.
Clarivate elects Kenneth Cornick to board; board expands to 11 members
Effective July 22, 2025, Kenneth Cornick elected to Clarivate board, increasing director count from 10 to 11.
Clarivate closes $500M incremental term loan, redeems $500M of 2026 notes
New $500M incremental term B loans added under credit agreement, maturing 2031, interest rate of Term SOFR + 3.25%.
Camelot Finance S.A., a Clarivate subsidiary, gives notice to redeem $500M of its 4.50% Senior Secured Notes due 2026.
Clarivate shareholders approve all 2025 AGM proposals, including share repurchase authorization
All five director nominees elected; e.g., Andrew Snyder received 609M votes for and 19M against.
Clarivate Q1 rev $593.7M (-4.4% YoY); organic +0.3%; net loss widens; outlook reaffirmed
Total revenue $593.7M (-4.4% YoY); organic revenue up 0.3%, recurring organic +0.6%.
Director Michael J. Angelakis to retire from Clarivate board, effective May 7, 2025
Michael J. Angelakis notified his retirement from the Board, effective upon re-election at 2025 Annual Meeting on May 7, 2025.
Clarivate Q4 revenue $663M (-3% YoY), adj. EPS $0.21; initiates strategic alternatives review
Full year 2024 revenue $2.56B (-2.7% YoY); net loss -$636.7M improved from -$911.2M.
Clarivate authorizes $500M share repurchase program for 2025-2026
Board authorized $500M share repurchase via open-market buys from Jan 1, 2025 to Dec 31, 2026.
Clarivate amends Richard Roedel board retirement effective date to Jan 1, 2025
Director Richard Roedel retirement originally set for Dec 31, 2024; now effective Jan 1, 2025.
Clarivate Q3 revenue down 3.9%, posts net loss; withdraws 2024 outlook
Revenue $622.2M (-3.9% YoY); organic revenue -2.6% with transactional sales down 13.6%.
Clarivate appoints Matti Shem Tov as CEO effective Aug 9; Jonathan Gear steps down
Gear receives $4.375M lump sum, pro-rated bonus, accelerated RSUs, and 18 months COBRA reimbursement.
Clarivate Q2 2024 revenue down 2.8%, adjusted EPS $0.20, reaffirms FY outlook
Revenues $650.3M, down 2.8% YoY; organic revenue declined 0.6% with subscription growth offset by transactional/other.
Director Richard Roedel to retire; Valeria Alberola to succeed as Audit Chair
Richard Roedel will retire from Clarivate Board for health reasons, effective Dec 31, 2024.
Clarivate shareholders elect 12 directors, approve say-on-pay and auditor at 2024 AGM
All 12 director nominees elected with majority support; notable against votes for Wendell Pritchett (45M), Richard Roedel (41M).
Clarivate Q1 net loss $93.8M; revenue down 1.3%; adjusted EPS -22%
Net loss per diluted share $0.14 vs income $0.04 YoY; adjusted diluted EPS $0.14, down 22.2%.
Clarivate enters investment pact with Exor; Exor to nominate director, subject to standstill
Exor, holding 10.1% of Clarivate shares, will nominate its COO Suzanne Heywood for board election at 2024 annual meeting.
Clarivate Q4 net loss $863M on $845M impairment; adj EPS $0.23 +4.5%
Q4 revenues $683.7M +1.2% YoY; organic revenue growth 0.1%.
Clarivate refinances $2.15B term loan, lowers margin and extends revolver to 2029
New $2.150 billion term loan tranche matures in 2031 at SOFR + 275 bps, down from prior margin.
Clarivate launches $2.2B term loan refinancing; expects $800M-$900M goodwill impairment in Q4 2023
Refinancing of 2026 Term Loan B with new $2.2B, 7-year facility maturing in 2031, subject to market conditions.
Clarivate Q3 revenues $647M, up 1.8%; adj. EPS $0.21, up 5%; reaffirms FY23 outlook
Revenue $647.2M, up 1.8% vs Q3 2022; organic revenue growth 1.7%.
Clarivate terminates Tax Benefits Preservation Plan effective Oct 1, 2023
Board unanimously approved termination; plan expires at end of day October 1, 2023.
Clarivate Q2 net loss $141.7M; revenue down 2.6%; lowers 2023 outlook
Revenue $668.8M (-2.6% YoY); organic revenue -0.4%. Net loss $141.7M vs. income $43.7M prior year.
Shareholders authorize open-market share repurchases at Clarivate
Shareholders approved share repurchase authorization at July 27, 2023 meeting.
Clarivate presents at conferences; no material financial details in filing
CEO Jonathan Gear presenting at William Blair Growth Stock Conference on June 6, 2023.
Clarivate extends share buyback authorization to Dec 2024, reduces to $500M
Board reduced authorization from $1B to $500M and extended through Dec 31, 2024.
Clarivate 2023 AGM: all director nominees elected, say-on-pay and auditor ratified
Shareholders elected all 11 director nominees; each received >94% of votes cast excluding broker non-votes.
Clarivate Q1 revenue $629M (-5% YoY); adj. EPS $0.18; CRO departs; reaffirms FY outlook
Revenue $629.1M (-5% YoY; -3.1% constant currency); organic revenue -0.2% due to MarkMonitor divestiture and FX.
Clarivate reiterates 2023 outlook at Investor Day; revenue $2.63B-$2.73B, Adj. EBITDA $1.10B-$1.16B
Reaffirmed 2023 guidance: revenue $2.63B-$2.73B, organic growth 2.75%-3.75%.
Q4 revenue $675.3M (+20.4% YoY); organic revenue +0.5%; subscription +2.5% organic.
Clarivate adopts tax benefits preservation plan to protect over $1.0B in NOLs
Board declared dividend of one preferred share purchase right per ordinary share payable Jan 1, 2023.
CEO Jonathan Gear passed 100-day mark; letter details key objectives for next year.
Clarivate board reduced from 14 to 11; three directors resign voluntarily
Directors Balakrishnan Iyer, Kosty Gilis, Roxane White resigned effective Dec 19, 2022.
Clarivate furnishes 2021 financial data; no narrative summary extractable from raw XBRL
Filing is an 8.01 furnishing of financial statements (Exhibit 99) for fiscal year 2021.
Clarivate presents at RBC conference with business overview and financial outlook
Company management presented at RBC Capital Markets TMT conference on November 15, 2022.
Revenue $635.7M (+43.8% YoY); organic revenue +1.2%; subscription organic +4.3%.
Clarivate completes divestiture of MarkMonitor to Newfold Digital for $302.5M
Sale price $302.5M; $10.6M expected from deferred closings in foreign jurisdictions.
Clarivate sells MarkMonitor domain management to Newfold Digital for ~$302.5M cash
Purchase price ~$302.5M: $292.5M at initial close, $10M deferred; close expected late 2022.
Maroun S. Mourad, President, Intellectual Property of Clarivate Plc (the “Company”) will depart from his position, effective June 9, 2026.
On February 25, 2025, Michael J. Angelakis notified Clarivate Plc (the “Company”) of his decision to retire from the Board of Directors of the Company (the “Board”), effective upon the re-election of members of the Board at the Company’s 2025 Annual General Meeting of Shareholders to be held on May 7, 2025, and withdrew from consideration for re-election as a member of the Board.
Jonathan Gear, Chief Executive Officer of Clarivate Plc (the “Company”) will depart from his position and step down as a member of the board of directors (the “Board”), effective August 9, 2024.
On August 6, 2024, the Company announced that Matitiahu (Matti) Shem Tov, age 63, will assume the role of Chief Executive Officer and will join the Board, effective as of August 9, 2024.
On July 23, 2024, Richard Roedel notified Clarivate Plc (the “Company”) of his retirement from the Board of Directors of the Company, effective as of December 31, 2024.
Steen Lomholt-Thomsen, Chief Revenue Officer of Clarivate Plc (the “Company”) will depart from his position, effective July 1, 2023.
Balakrishnan Iyer, Konstantin Gilis and Roxane White, members of the board of directors, were stepping down from the board, effective on December 19, 2022.
Balakrishnan Iyer, Konstantin Gilis and Roxane White, members of the board of directors, were stepping down from the board, effective on December 19, 2022.
Balakrishnan Iyer, Konstantin Gilis and Roxane White, members of the board of directors, were stepping down from the board, effective on December 19, 2022.
Mr. Stead has informed Clarivate that following the Board meeting scheduled for October 20, 2022, he will retire from the Board of Directors.
the retirement of Jerre Stead from that role.
Jonathan Gear had assumed the role of Chief Executive Officer with the retirement of Jerre Stead from that role.
Max materiality 0.85 · Median 0.60 · Most common event other_material